A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Put together by software, not yet checked by a person
Why this status
13 Aug 2015: Trial registered, NCT02521493
23 Dec 2015: Trial started, NCT02521493
The trials
NCT02521493: Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
State
Under way
Phase
Phase 3
People
280 taking part
Started
23 Dec 2015
Primary completion
30 Jun 2024
Arms
Arm A (standard risk)
Results
Posted on the registry
13 Aug 2015: Trial registered
23 Dec 2015: Trial started
13 Jun 2025: Trial results posted
How the status changed
19 Nov 2026: First set: Phase 3 trial
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.